Amphiphilic Zwitterionic Polymers Induce Liposome Morphogenesis into Nanodiscs for Deep Glioblastoma Infiltration

Y Yeying Li (College of Pharmacy Anhui University of Chinese Medicine Hefei China) X Xiaopeng Xu T Teng Hao X Xiujie Mao (Shandong Laboratory of Yantai Drug Discovery Bohai Rim Drug Advanced Research Institute Yantai China) P Peng Guo X Xiaojing Zhu (Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University) W Wenrui Jin (Shandong Laboratory of Yantai Drug Discovery Bohai Rim Drug Advanced Research Institute Yantai China) H Haoran Geng (College of Pharmacy Anhui University of Chinese Medicine Hefei China) F Fang Li X Xi Hu (Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University) D Dongliang Guan Z Zhenyong Wu (Shandong Laboratory of Yantai Drug Discovery)

Abstract

ABSTRACT Glioblastoma therapy is severely constrained by the blood–brain barrier (BBB) and limited intratumoral penetration. Here, we report a de novo synthesized amphiphilic zwitterionic copolymer that co‐assembles with phospholipids into protein‐free nanodiscs (zNDs, ∼15.5 nm). Liposome co‐flotation and Förster resonance energy transfer (FRET) assays reveal a three‐stage morphogenetic process: polymer insertion, membrane disruption, and liposome‐to‐nanodisc reassembly through membrane remodeling. The resulting zNDs exhibit high colloidal stability under physiological conditions and efficiently cross the BBB via choline transporter‐mediated transcytosis. In orthotopic glioblastoma models, zNDs penetrate tumors deeply, enter cells through clathrin‐mediated endocytosis, and escape endo‐lysosomal compartments. Incorporation of lipid–drug conjugates allows delivery of honokiol, which disassembles 3D tumor spheroids, suppresses tumor growth in orthotopic models, and extends median survival by nearly 2.5‐fold without systemic toxicity. This study establishes a modular, protein‐free nanodisc platform that integrates rational polymer design with active BBB transport, offering a versatile strategy for deep therapeutic delivery in central nervous system malignancies and providing mechanistic principles that guide future optimization of BBB‐penetrant nanocarriers.

Article Details

Volume / Issue Vol. 65, Issue 21
Published May 18, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (12)

Y

Yeying Li

College of Pharmacy Anhui University of Chinese Medicine Hefei China

X

Xiaopeng Xu

T

Teng Hao

X

Xiujie Mao

Shandong Laboratory of Yantai Drug Discovery Bohai Rim Drug Advanced Research Institute Yantai China

P

Peng Guo

X

Xiaojing Zhu

Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University

W

Wenrui Jin

Shandong Laboratory of Yantai Drug Discovery Bohai Rim Drug Advanced Research Institute Yantai China

H

Haoran Geng

College of Pharmacy Anhui University of Chinese Medicine Hefei China

F

Fang Li

X

Xi Hu

Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University

D

Dongliang Guan

Z

Zhenyong Wu

Shandong Laboratory of Yantai Drug Discovery